P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 156,843 shares at $341.02 ($52.6M) on 2014-08-11, disclosed to the SEC on 2014-08-11.
Open-market sale of $52.6M REGN by Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 764 | $0 | 0.0% |
| 2 | $0.00 | 700 | $0 | 0.0% |
| 3 | $0.00 | 756 | $0 | 0.0% |
| 4 | $340.12 | 135,108 | $46.0M | 87.4% |
| 5 | $340.12 | 7,543 | $2.6M | 4.9% |
| 6 | $340.33 | 2,600 |
| $885K |
| 1.7% |
| 7 | $340.02 | 9,072 | $3.1M | 5.9% |
| 8 | $341.02 | 300 | $102K | 0.2% |
| Total | $335.31 avg | 156,843 | $52.6M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |